Publications by authors named "William Bensinger"

89Publications

Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.

Acta Haematol 2017 30;137(3):123-131. Epub 2017 Mar 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000455937DOI Listing
July 2017

A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma?

Curr Hematol Malig Rep 2017 02;12(1):61-67

Myeloma & Transplant Program, Swedish Cancer Institute, 1221 Madison Street, Suite 1007, Seattle, WA, 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0365-2DOI Listing
February 2017

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

Biol Blood Marrow Transplant 2016 09 14;22(9):1582-1587. Epub 2016 Jun 14.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981519PMC
September 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Panobinostat: a review of trial results and future prospects in multiple myeloma.

Expert Rev Hematol 2015 Feb 20;8(1):9-18. Epub 2014 Nov 20.

University of Washington School of Medicine - Medical Oncology, 825 Eastlake Ave E, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.983065DOI Listing
February 2015

Allogeneic stem cell transplantation for multiple myeloma.

Hematol Oncol Clin North Am 2014 Oct 25;28(5):891-902. Epub 2014 Jul 25.

Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D5-390, Seattle, WA 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.06.001DOI Listing
October 2014

A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

Cancer Res 2014 Feb 26;74(4):1179-89. Epub 2013 Dec 26.

Authors' Affiliations: Clinical Research Division, Fred Hutchinson Cancer Research Center; Departments of Medicine, Radiation Oncology, and Laboratory Medicine, University of Washington, Seattle; and Dade Moeller Health Group, Richland, Washington.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/74/4/1179.full.pdf
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970848PMC
February 2014

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.

Br J Haematol 2012 Oct 4;159(1):58-66. Epub 2012 Aug 4.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09251.xDOI Listing
October 2012

The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells.

J Clin Apher 2012 2;27(2):81-7. Epub 2012 Feb 2.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jca.21206
Publisher Site
http://dx.doi.org/10.1002/jca.21206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004340PMC
August 2012

Allogeneic transplantation: peripheral blood vs. bone marrow.

Curr Opin Oncol 2012 Mar;24(2):191-6

Division of Clinical Research, The Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32834f5c27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624903PMC
March 2012

The treatment of elderly patients with multiple myeloma: is more better?

Oncology (Williston Park) 2010 Oct;24(11):1004, 1006

University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
October 2010

High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1899-906

Akademia Medyczna w Gdansku, 80-210 Gdansk, ul. M., Sklodowskiej-Curie 3a, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802340184DOI Listing
October 2008

Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?

Best Pract Res Clin Haematol 2007 Dec;20(4):783-95

University of Washington, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-390, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2007.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017399PMC
December 2007

Stem-cell transplantation for multiple myeloma in the era of novel drugs.

J Clin Oncol 2008 Jan 3;26(3):480-92. Epub 2007 Dec 3.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.6863DOI Listing
January 2008

Initial Therapy of Multiple Myeloma in Patients who are Candidates for Stem Cell Transplantation.

Curr Treat Options Oncol 2007 Apr;8(2):135-43

Fred Hutchinson Cancer Research Center, D5-390 1100 Fairview Avenue N., Seattle, WA 98118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-007-0027-zDOI Listing
April 2007

Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.

Biol Blood Marrow Transplant 2007 Jul 23;13(7):806-13. Epub 2007 Apr 23.

Health Services Research, Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791070019
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2007.03.004DOI Listing
July 2007

Reduced intensity allogeneic stem cell transplantation in multiple myeloma.

Front Biosci 2007 May 1;12:4384-92. Epub 2007 May 1.

University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/2395DOI Listing
May 2007

Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma.

Clin Lymphoma Myeloma 2006 Sep;7(2):135-9

Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.051DOI Listing
September 2006

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.

Biol Blood Marrow Transplant 2006 Feb;12(2):226-34

Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910500681
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2005.10.011DOI Listing
February 2006

Improved conditioning regimens for autologous transplantation using targeted radiotherapy.

Acta Haematol 2005 ;114(4):230-8

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000088414DOI Listing
December 2005

Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.

Int J Radiat Oncol Biol Phys 2006 Jan 19;64(1):227-34. Epub 2005 Sep 19.

Fred Hutchinson Cancer Research Center, University of Washington, Clinical Research Division, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.06.005DOI Listing
January 2006

The current status of hematopoietic stem cell transplantation for multiple myeloma.

Clin Adv Hematol Oncol 2004 Jan;2(1):46-52

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
January 2004

Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.

Oncology 2004 ;67(5-6):368-75

Fred Hutchinson Cancer Research Center, and University of Washington School of Medicine Seattle, Wash., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000082920DOI Listing
February 2005

Palifermin for oral mucositis after intensive therapy for hematologic cancers.

N Engl J Med 2004 Dec;351(25):2590-8

City of Hope National Medical Center, Department of Hematology and Hematopoietic Cell Transplantation and Kaiser Permanente BMT Program, Duarte, Calif 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa040125DOI Listing
December 2004

The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.

J Natl Compr Canc Netw 2004 Jul;2(4):371-8

University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2004.0030DOI Listing
July 2004

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.

Blood 2004 Sep 29;104(6):1894-7. Epub 2004 Apr 29.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Human Immunogenetics Program, 1100 Fairview Ave N, D2-100, PO Box 19024, Seattle, WA 98109-19024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-02-0508DOI Listing
September 2004

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.

Biol Blood Marrow Transplant 2003 Jun;9(6):405-13

Department of Hematology/Oncology, University of California-San Francisco, 400 Parnassus Avenue, Room A502, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1083-8791(03)00101-0DOI Listing
June 2003

Recent developments in hematopoietic stem cell transplantation for multiple myeloma.

Int J Hematol 2003 Apr;77(3):232-8

University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02983779DOI Listing
April 2003

High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.

J Nucl Med 2002 Oct;43(10):1383-90

Department of Radiology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
October 2002

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.

Biol Blood Marrow Transplant 2002 ;8(5):281-9

Fred Hutchinson Cancer Research Center, Seattle Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.pm12064366DOI Listing
July 2003